BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9209899)

  • 21. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
    Fraser IS; Shearman RP; Jansen RP; Sutherland PD
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
    Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    Riis BJ; Christiansen C; Johansen JS; Jacobson J
    J Clin Endocrinol Metab; 1990 Apr; 70(4):920-4. PubMed ID: 2138631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan.
    Cheng MH; Yu BK; Chang SP; Wang PH
    J Chin Med Assoc; 2005 Jul; 68(7):307-14. PubMed ID: 16038370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafarelin in the treatment of endometriosis. Dose management.
    Hull ME; Barbieri RL
    Gynecol Obstet Invest; 1994; 37(4):263-4. PubMed ID: 8050732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial.
    Finkelstein JS; Klibanski A; Arnold AL; Toth TL; Hornstein MD; Neer RM
    JAMA; 1998 Sep 23-30; 280(12):1067-73. PubMed ID: 9757854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of treating endometriosis with nafarelin].
    Marianowski L; Kamiński P
    Wiad Lek; 1994 Aug; 47(15-16):595-7. PubMed ID: 7716957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of pelvic endometriosis with goserelin acetate or nafarelin acetate. Comparative study].
    Calvo Lugo GE; Sauceda González LF; Jiménez Perea ML; Díaz Arias FJ
    Ginecol Obstet Mex; 2000 Jan; 68():7-14. PubMed ID: 10774095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of nafarelin acetate and danazol in the treatment of endometriosis.
    Kennedy SH; Williams IA; Brodribb J; Barlow DH; Shaw RW
    Fertil Steril; 1990 Jun; 53(6):998-1003. PubMed ID: 2140996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crohn's disease mimicking as bowel endometriosis. Are the symptoms reduced by nafarelin acetate?
    Nakao A; Iwagaki H; Kanagawa T; Jikuhara A; Matsubara N; Takakura N; Isozaki H; Tanaka N
    Arch Gynecol Obstet; 2000 Feb; 263(3):131-3. PubMed ID: 10763842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.
    Hornstein MD; Surrey ES; Weisberg GW; Casino LA
    Obstet Gynecol; 1998 Jan; 91(1):16-24. PubMed ID: 9464714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis].
    Palatyński A; Gruszczyńska J; Sobkiewicz S
    Ginekol Pol; 2001 May; 72(5):284-9. PubMed ID: 11526758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative study of the efficiency of gonadotrope releasing hormone (GnRH) analogs for the treatment of endometriosis].
    Keresztúri A; Daru J; Pál A
    Orv Hetil; 2002 Jun; 143(24):1475-8. PubMed ID: 12138645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
    Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
    Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial.
    Parazzini F; Fedele L; Busacca M; Falsetti L; Pellegrini S; Venturini PL; Stella M
    Am J Obstet Gynecol; 1994 Nov; 171(5):1205-7. PubMed ID: 7977520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis.
    Zhao SZ; Arguelles LM; Wong JM; Davis MB; Gersh GE; Struthers BJ
    Clin Ther; 1998; 20(3):592-602. PubMed ID: 9663373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of norethindrone acetate in the treatment of symptomatic endometriosis.
    Muneyyirci-Delale O; Karacan M
    Int J Fertil Womens Med; 1998; 43(1):24-7. PubMed ID: 9532466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nafarelin versus danazol in the treatment of endometriosis.
    Rolland R; van der Heijden PF
    Am J Obstet Gynecol; 1990 Feb; 162(2):586-8. PubMed ID: 2137976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.